Primary |
Hiv Infection |
63.0% |
Acquired Immunodeficiency Syndrome |
6.5% |
Prophylaxis Against Hiv Infection |
6.5% |
Antiretroviral Therapy |
5.4% |
Cytomegalovirus Chorioretinitis |
4.3% |
Drug Use For Unknown Indication |
4.3% |
Opportunistic Infection Prophylaxis |
3.3% |
Product Used For Unknown Indication |
2.2% |
Prophylaxis |
2.2% |
Antiviral Treatment |
1.1% |
Retroperitoneal Cancer |
1.1% |
|
Eyelid Function Disorder |
6.9% |
Maternal Drugs Affecting Foetus |
6.9% |
Meningitis Coccidioides |
6.9% |
Necrotising Colitis |
6.9% |
Nephrolithiasis |
6.9% |
Osteoporosis |
6.9% |
Rash |
6.9% |
Stillbirth |
6.9% |
Uveitis |
6.9% |
Abortion Spontaneous |
3.4% |
Acute Promyelocytic Leukaemia |
3.4% |
Blood Pressure Abnormal |
3.4% |
Drug Exposure During Pregnancy |
3.4% |
Eyelid Ptosis |
3.4% |
Feeding Disorder Neonatal |
3.4% |
Hydrocele |
3.4% |
Lipodystrophy Acquired |
3.4% |
Myocardial Infarction |
3.4% |
Neurofibromatosis |
3.4% |
Portal Hypertension |
3.4% |
|
Secondary |
Hiv Infection |
72.6% |
Antiretroviral Therapy |
15.5% |
Prophylaxis Against Transplant Rejection |
2.6% |
Drug Exposure During Pregnancy |
1.8% |
Antiviral Prophylaxis |
1.5% |
Product Used For Unknown Indication |
1.4% |
Drug Use For Unknown Indication |
1.0% |
Prophylaxis Against Hiv Infection |
0.9% |
Antiviral Treatment |
0.6% |
Acquired Immunodeficiency Syndrome |
0.4% |
Acute Hiv Infection |
0.3% |
Ill-defined Disorder |
0.3% |
Maternal Exposure During Pregnancy |
0.2% |
Maternal Exposure Timing Unspecified |
0.2% |
Progressive Multifocal Leukoencephalopathy |
0.2% |
Prophylaxis |
0.2% |
Intracranial Pressure Increased |
0.1% |
Pneumocystis Jiroveci Pneumonia |
0.1% |
Tuberculosis |
0.1% |
Chronic Obstructive Pulmonary Disease |
0.1% |
|
Progressive External Ophthalmoplegia |
21.8% |
Maternal Drugs Affecting Foetus |
7.7% |
Osteonecrosis |
7.1% |
Drug Exposure During Pregnancy |
5.8% |
Transplant Rejection |
5.8% |
Urine Colour Abnormal |
5.8% |
Premature Baby |
5.1% |
Drug Resistance |
4.5% |
Pregnancy |
4.5% |
Varices Oesophageal |
4.5% |
Parkinsonism |
3.8% |
Splenomegaly |
3.8% |
Osteoporosis |
3.2% |
Virologic Failure |
3.2% |
Maternal Exposure During Pregnancy |
2.6% |
Sickle Cell Anaemia |
2.6% |
Treatment Failure |
2.6% |
Cryptorchism |
1.9% |
Hepatobiliary Disease |
1.9% |
Ileal Atresia |
1.9% |
|
Concomitant |
Hiv Infection |
57.3% |
Drug Exposure During Pregnancy |
9.8% |
Convulsion Prophylaxis |
8.1% |
Acquired Immunodeficiency Syndrome |
4.9% |
Antiretroviral Therapy |
4.1% |
Coronary Artery Disease |
2.0% |
Renal And Pancreas Transplant |
2.0% |
Gastritis |
1.6% |
Infection Prophylaxis |
1.6% |
Diarrhoea |
1.2% |
Factor Viii Deficiency |
1.2% |
Non-hodgkin's Lymphoma |
1.2% |
Prophylaxis Against Hiv Infection |
1.2% |
Antibiotic Prophylaxis |
0.8% |
Hepatitis C |
0.8% |
Aids Related Complication |
0.4% |
Antiviral Prophylaxis |
0.4% |
Asthma |
0.4% |
Cd4 Lymphocytes Decreased |
0.4% |
Colony Stimulating Factor Prophylaxis |
0.4% |
|
Pyrexia |
14.3% |
Fallot's Tetralogy |
10.7% |
Hepatitis C |
7.1% |
Hypospadias |
7.1% |
Umbilical Hernia |
7.1% |
Activated Partial Thromboplastin Time Prolonged |
3.6% |
Adrenal Suppression |
3.6% |
Congenital Hip Deformity |
3.6% |
Depression |
3.6% |
Drug Resistance |
3.6% |
Hallucination |
3.6% |
Hip Dysplasia |
3.6% |
Hyperglycaemia |
3.6% |
Hypoglycaemia |
3.6% |
Ileal Atresia |
3.6% |
Maternal Condition Affecting Foetus |
3.6% |
Nephrotic Syndrome |
3.6% |
Nervous System Disorder |
3.6% |
Neutropenic Sepsis |
3.6% |
Palpitations |
3.6% |
|